Company profile
ABSCINT
ABSCINT, Harnessing Antibody Scintigraphy for Precision Diagnostics in Breast Cancer and Beyond
- Industry
- Biotechnology Research
- Employees
- 10
- Headquarters
- Liège
- Founded
- 2020
- Office locations
- 1
ABSCINT company summary
ABSCINT is a company in the Biotechnology Research industry, headquartered in Liège, founded in 2020. On LinkedIn the company has around 10 employees. Its listed specialties include Radiopharmaceuticals, Precision imaging, Breast cancer, Molecular imaging, Diagnostics.
What technology does ABSCINT use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ABSCINT
ABSCINT specializes in advanced in vivo imaging diagnostics, focusing on developing innovative PET tracers using single-domain antibodies (sdAbs) for precision targeting. ABSCINT’s primary product is a specific anti-HER2 PET tracer, which enables comprehensive whole-body imaging for evaluating disease heterogeneity in HER2-low and HER2-positive breast cancer. This non-invasive technology offers rapid imaging results within 90 minutes, with minimal radiation exposure. This innovation also opens the door to HER2 reclassification via image-guided biopsies, enhancing diagnostic accuracy, patient care, and monitoring of treatment efficacy. -- ABSCINT, Harnessing Antibody Scintigraphy for Precision Diagnostics in Breast Cancer and Beyond --
Specialties
Where is ABSCINT located?
ABSCINT lists 1 location.
Compare companies similar to ABSCINT
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ABSCINT abscint.com | Biotechnology Research | 10 | 2020 | Liège |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ABSCINT
What does ABSCINT do?
ABSCINT specializes in advanced in vivo imaging diagnostics, focusing on developing innovative PET tracers using single-domain antibodies (sdAbs) for precision targeting. ABSCINT’s primary product is a specific anti-HER2 PET tracer, which enables comprehensive whole-body imaging for evaluating disease heterogeneity in HER2-low and HER2-positive breast cancer. This non-invasive technology offers rapid imaging results within 90 minutes, with minimal radiation exposure. This innovation also opens the door to HER2 reclassification via image-guided biopsies, enhancing diagnostic accuracy, patient care, and monitoring of treatment efficacy. -- ABSCINT, Harnessing Antibody Scintigraphy for Precision Diagnostics in Breast Cancer and Beyond --
How many employees does ABSCINT have?
ABSCINT has around 10 employees on LinkedIn.
Where is ABSCINT headquartered?
ABSCINT is headquartered in Liège.
When was ABSCINT founded?
ABSCINT was founded in 2020.
Build a lead list from companies like ABSCINT
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.